Survivin, the promising target in hepatocellular carcinoma gene therapy

Cancer Biol Ther. 2008 Apr;7(4):555-6. doi: 10.4161/cbt.7.4.5891. Epub 2008 Mar 12.

Authors

Jie Liu¹, Wenqi Du, Daiming Fan

Affiliation

¹ State Key Laboratory of Cancer Biology and Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, P. R. China. Jieliu@fmmu.edu.cn

PMID: 18364566
DOI: 10.4161/cbt.7.4.5891

No abstract available

Publication types

Comment

MeSH terms

Apoptosis
Carcinoma, Hepatocellular / therapy*
Genetic Therapy*
Humans
Inhibitor of Apoptosis Proteins
Liver Neoplasms / therapy*
Microtubule-Associated Proteins / genetics*
Neoplasm Proteins / genetics*
Point Mutation*
Survivin

Substances

BIRC5 protein, human
Inhibitor of Apoptosis Proteins
Microtubule-Associated Proteins
Neoplasm Proteins
Survivin